Depression: clinical features
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Depression: clinical features. The 12-month prevalence is 6.6%. The lifetime prevalence is 16.2%. Fully referenced neurology checklist.
Prevalence
- The 12-month prevalence is 6.6%
- The lifetime prevalence is 16.2%
Genetic risk factors
Locked: subscribe to see this section.
Environmental risk factors
Locked: subscribe to see this section.
Epidemiological risk factors
Locked: subscribe to see this section.
Clinical features
Locked: subscribe to see this section.
Symptom groups
Locked: subscribe to see this section.
Co-morbid disorders
Locked: subscribe to see this section.
Monoamine deficiency hypotheses
Locked: subscribe to see this section.
Magnetic resonance imaging (MRI) brain
Locked: subscribe to see this section.
Synonym
Locked: subscribe to see this section.
References
- Cui L, Li S, Wang S, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther 2024; 9:30.
- Rush AJ. The varied clinical presentations of major depressive disorder. J Clin Psychiatry 2007; 68(Suppl 8):4-10.
- Li Z, Ruan M, Chen J, Fang Y. Major depressive disorder: advances in neuroscience research and translational applications. Neurosci Bull 2021; 37:863-880.
